“In Silico Assessment of Chemical Constituents of Zingiber officinale Rosc. For Anti-diabetic Activity: Molecular Docking with α-Glucosidase Receptor”, Pharm.biomed.Sci.J, vol. 5, no. 2, pp. 132–142, Dec. 2023, doi: 10.15408/pbsj.v5i2.36161.